Total Funding
31
10
Total FundingSeries A raised
Growth Score 31 in past quarter
-3 pts
Heat Score 10 in past quarter
-28 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
175003
Phi Pharma is a private Swiss-based biopharmaceutical company.
Emmanuel Savioz: Co-founder, Chairman and Chief Financial Officer
Tom Shepherd: Chief Executive OfficerPast Role: Kymab, Chief Business Officer
About the Company
Phi Pharma is a private Swiss-based biopharmaceutical company. It specializes in the discovery and early clinical development of drug conjugates for improving treatment of diseases with high-medical need. Phi Pharma technology allows development of a powerful new class of peptide drug conjugates through specific cellular targeting and efficient
intra-cellular delivery. Company programs are in oncology and infectious diseases.
